Lin Jiang
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Cancer, Hypoxia, and Metabolism
- Molecular Biology top 10%
- RNA modifications and cancer
- Circular RNAs in diseases
Papers in
- Surgery 20
- Cholangiocarcinoma and Gallbladder Cancer Studies 10
- Coronary Interventions and Diagnostics 5
- Co-authors
- Yingbin Liu (24 shared papers)Yunping Hu (19 shared papers)Xiangsong Wu (9 shared papers)Yijian Zhang (12 shared papers)Yang Cao (8 shared papers)Maolan Li (10 shared papers)Shanshan Xiang (8 shared papers)Yuanyuan Ye (7 shared papers)
- Journals
- Nutrition Metabolism and Cardiovascular Diseases (4 papers)Frontiers in Cardiovascular Medicine (3 papers)Cardiovascular Diabetology (3 papers)Journal of Diabetes (2 papers)Cell Death and Disease (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Lin Jiang
90 papers receiving 2.0k citations
Lin Jiang's Hit Papers
Peers
Comparison fields: 5 of 99
- Cancer Research 520
- Molecular Biology 767
- Oncology 274
- Pulmonary and Respiratory Medicine 191
- Pharmacology 98
Countries citing papers authored by Lin Jiang
This map shows the geographic impact of Lin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Jiang more than expected).
Fields of papers citing papers by Lin Jiang
This network shows the impact of papers produced by Lin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Jiang. The network helps show where Lin Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Lin Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 97 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Comprehensive metabolomics expands precision medicine for triple-negative breast cancer Hit paper breakdown → | 2022 | 220 |
| 2 | 2015 | 104 | |
| 3 | 2016 | 95 | |
| 4 | 2018 | 85 | |
| 5 | 2018 | 78 | |
| 6 | 2017 | 72 | |
| 7 | 2019 | 67 | |
| 8 | 2022 | 65 | |
| 9 | 2015 | 64 | |
| 10 | 2017 | 64 | |
| 11 | 2017 | 61 | |
| 12 | 2022 | 46 | |
| 13 | 2014 | 41 | |
| 14 | 2016 | 40 | |
| 15 | 2019 | 39 | |
| 16 | 2019 | 37 | |
| 17 | 2016 | 37 | |
| 18 | 2019 | 36 | |
| 19 | 2015 | 32 | |
| 20 | 2015 | 29 |
About Lin Jiang
Lin Jiang is a scholar working on Molecular Biology, Surgery, Cancer Research, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine, having authored 97 papers that have together received 2.0k indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), Cancer-related molecular mechanisms research (9 papers), Gastric Cancer Management and Outcomes (7 papers), MicroRNA in disease regulation (7 papers), Cardiac Imaging and Diagnostics (5 papers), Coronary Interventions and Diagnostics (5 papers), Acute Myocardial Infarction Research (4 papers) and Nutrition and Health in Aging (3 papers). The work is most often cited by research in Cancer Research (520 citations), Molecular Biology (767 citations), Oncology (274 citations), Pulmonary and Respiratory Medicine (191 citations) and Pharmacology (98 citations). Lin Jiang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yingbin Liu, Yunping Hu, Xiangsong Wu, Yijian Zhang, Yang Cao, Maolan Li, Shanshan Xiang, Yuanyuan Ye, Yi Xiao and Fei Zhang. Their work appears in journals such as Nutrition Metabolism and Cardiovascular Diseases, Frontiers in Cardiovascular Medicine, Cardiovascular Diabetology, Journal of Diabetes and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.